2,550 Shares in CVS Health Co. (NYSE:CVS) Bought by High Net Worth Advisory Group LLC

High Net Worth Advisory Group LLC acquired a new stake in CVS Health Co. (NYSE:CVS) during the 1st quarter, Holdings Channel reports. The institutional investor acquired 2,550 shares of the pharmacy operator’s stock, valued at approximately $203,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Birch Capital Management LLC boosted its holdings in CVS Health by 10.6% in the 1st quarter. Birch Capital Management LLC now owns 68,806 shares of the pharmacy operator’s stock worth $5,488,000 after acquiring an additional 6,602 shares during the period. Bridge Creek Capital Management LLC lifted its position in shares of CVS Health by 1.0% during the first quarter. Bridge Creek Capital Management LLC now owns 54,822 shares of the pharmacy operator’s stock worth $4,373,000 after purchasing an additional 542 shares in the last quarter. Douglas Lane & Associates LLC increased its stake in CVS Health by 1.6% during the 1st quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock worth $86,480,000 after buying an additional 16,840 shares during the period. &PARTNERS purchased a new stake in shares of CVS Health during the first quarter worth about $430,000. Finally, Sanders Morris Harris LLC raised its holdings in CVS Health by 4.1% in the first quarter. Sanders Morris Harris LLC now owns 5,774 shares of the pharmacy operator’s stock valued at $461,000 after acquiring an additional 227 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity

In other news, Director Edward J. Ludwig bought 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.24% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CVS shares. UBS Group downgraded shares of CVS Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $85.00 to $60.00 in a research report on Thursday, May 2nd. Robert W. Baird began coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price for the company. Baird R W upgraded shares of CVS Health to a “hold” rating in a research report on Thursday, May 30th. Piper Sandler lifted their target price on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, March 15th. Finally, Mizuho dropped their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Eleven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $75.05.

CVS Health Stock Performance

CVS Health stock traded up $0.32 during trading hours on Monday, hitting $61.69. The stock had a trading volume of 1,689,569 shares, compared to its average volume of 12,049,563. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a market cap of $77.44 billion, a PE ratio of 10.79, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. The company has a 50-day moving average of $60.47 and a two-hundred day moving average of $70.64. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.20 EPS. On average, equities research analysts anticipate that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.